$1,000.00
Zepbound is an injectable prescription medicine used for chronic weight management in adults. It is indicated for those with a body mass index (BMI) of at least 30 kg/m^2 or at least 27 kg/m^2 with at least one weight-related comorbid condition, and it should be administered alongside a reduced-calorie diet and increased physical activity. Zepbound, known by its generic name tirzepatide, targets both the GLP-1 and GIP hormones and has shown up to 21% weight loss in clinical trials. Common side effects reported include nausea, diarrhea, and vomiting.
In the competitive landscape of weight loss medications, Zepbound will primarily compete with Novo Nordisk’s Wegovy, which is a similar weight loss medication. The U.S. Food and Drug Administration (FDA) has also approved tirzepatide for treating obesity, and it is sold under the brand name Mounjaro when used as a diabetes medication, manufactured by Eli Lilly and Co.
Regarding cost, Zepbound is priced 20% less than its main competitor Wegovy for those with insurance coverage, though the cost remains high at over £500 for a month’s supply. Eli Lilly has announced a discount program for those whose insurance does not cover anti-obesity treatments, offering a 50% discount to these patients.
Product Description
Zepbound is a medication used to help manage blood sugar and promote weight loss in adults with type 2 diabetes. It is a once-weekly injection that combines two hormones called GLP-1 and GIP1. The generic name for Zepbound is Tirzepatide, and it is sometimes sold under the brand name Mounjaro. Zepbound contains the active ingredient Tirzepatide, a glucagon-like peptide-1 (GLP-1) receptor agonist and a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. The injection is formulated as a solution and is available in doses of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg per 0.5 mL single-dose pen.
Uses
Zepbound is primarily used to help manage blood sugar levels in adults with type 2 diabetes. However, it also has an added benefit of promoting weight loss. It works by increasing insulin secretion and slowing down the movement of food through the stomach.
Dosage
The recommended starting dose of Zepbound is 5 mg once a week, and it should be injected subcutaneously (under the skin). The dose may be increased to 10 mg once a week after 4 weeks, based on a patient’s response. The maximum recommended dose is 15 mg once a week.
Side Effects
Like all medications, Zepbound comes with potential side effects. Some of the reported side effects include:
Nausea
Vomiting
Diarrhea
Headache
Constipation
Abdominal pain
Injection site reactions
In rare cases, Zepbound can cause more serious side effects, such as:
Pancreatitis
Kidney problems
Hypoglycemia (low blood sugar)
Hypersensitivity reactions
Thyroid tumors
It is important to discuss any concerns or unexpected reactions with a healthcare provider. They can provide guidance and advice based on your specific situation.
Precautions
Before using Zepbound, inform your healthcare provider about any allergies, medical conditions, or medications you are currently taking. It is also important to inform your healthcare provider if you have a family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type. Zepbound is not recommended for people with type 1 diabetes or those who have a history of pancreatitis. It is also important to closely monitor blood sugar levels in people with a history of hypoglycemia.
Be the first to review “Zepbound”
Related products
Diabetes Medications
Diabetes Medications
Diabetes Medications
Diabetes Medications
Diabetes Medications
Diabetes Medications
Diabetes Medications
Diabetes Medications
Reviews
There are no reviews yet.